Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
CGD NOTES
December 14, 2022
Ensuring rapid and equitable access to effective oral COVID-19 therapies is essential to reducing health disparities from COVID-19 and building a better response system for future epidemics and pandemics. A multipronged strategy for medical countermeasures must include antivirals, monoclonal antibod...
Blog Post
December 14, 2022
It’s clear that COVID-19 oral antivirals are effective, and recent deals have made them even cheaper for African countries. But should these countries be investing in these medicines? Or would spending on alternative health services be better value for money? Unfortunately, there is very little avai...
CGD NOTES
December 14, 2022
Almost a year after two oral antiviral treatments received emergency use authorization, demand is extremely low. In this note, we argue that governments and their donor partners should use data and evidence to consider the economic and clinical rationale for registering, financing, purchasing, and d...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
Blog Post
December 12, 2022
Debt and climate change are defining challenges for many countries in Africa. Governments across the continent are seeing their debt burdens mount—some to unsustainable levels—as they race to mobilize resources to adapt and respond to the increasingly severe climate crisis.
Blog Post
December 07, 2022
How exactly should China's policymakers wade through competing models and guidance as it looks to ease its anti-COVID measures? This blog looks at how they should use models, using the case of the state of Hawaii; in sum, recommending that China’s National Health Commission take a thoughtful approac...
WORKING PAPERS
November 17, 2022
The large divergence in the returns of top-performing star firms and the rest of the economy is substantially reduced when we account for the mismeasurement of intangible capital. Star firms produce and invest more per dollar of invested capital, have more valuable innovations as measured by the mar...
Blog Post
November 17, 2022
How does public health surveillance work, and how can it be done better? Amanda Glassman tackles these questions with Dr. Oliver Morgan of the WHO and Dr. Theo Vos of the Institute for Health Metrics and Evaluation. Together, they examine the successes and limitations of public health surveillance d...
CGD NOTES
November 16, 2022
Inflation has become a central feature of the global economy. In Latin America (aside from idiosyncratic cases such as Argentina and Venezuela, where high inflation rates have long been the norm), inflation began to rise the first half of 2021, at the same time it did in the US. The fact that risin...